Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Tyra Biosciences
TYRA
$1.9B
| $34.5K | ﹤0.01% |
2,506
-282
| -10% | -$4.18K |
|
|
SSBK
3852
DELISTED
Southern States Bancshares
SSBK
| $34.5K | ﹤0.01% |
1,525
+13
| +0.9% | +$299 |
|
|
AFCG
3853
AFC Gamma
AFCG
$61.4M
| $34.4K | ﹤0.01% |
4,278
-497
| -10% | -$4.42K |
|
|
YMAB
3854
DELISTED
Y-mAbs Therapeutics
YMAB
| $34.3K | ﹤0.01% |
6,302
-1,015
| -14% | -$5.91K |
|
|
FIRY
3855
Firy Inc
FIRY
$148M
| $34.1K | ﹤0.01% |
6,691
-30,880
| -82% | -$274K |
|
|
CXAC
3856
DELISTED
C5 Acquisition Corporation
CXAC
| $34K | ﹤0.01% |
3,100
| – | – |
|
3857
iShares MSCI Poland ETF
EPOL
$700M
| $34K | ﹤0.01% |
1,985
| – | – |
|
|
URG
3858
Ur-Energy
URG
$485M
| $33.5K | ﹤0.01% |
21,782
| – | – |
|
|
BRT
3859
BRT Apartments
BRT
$281M
| $33.4K | ﹤0.01% |
1,936
-605
| -24% | -$11.4K |
|
3860
Novartis
NVS
$297B
| $33.4K | ﹤0.01% |
328
-10,650
| -97% | -$1.08M |
|
|
ITI
3861
DELISTED
Iteris, Inc.
ITI
| $33.4K | ﹤0.01% |
8,059
-561
| -7% | -$2.39K |
|
3862
Pure Cycle
PCYO
$253M
| $33.3K | ﹤0.01% |
3,471
-428
| -11% | -$4.83K |
|
3863
Stoke Therapeutics
STOK
$1.8B
| $33.3K | ﹤0.01% |
8,440
-6,389
| -43% | -$42K |
|
3864
C&F Financial
CFFI
$268M
| $33.1K | ﹤0.01% |
618
-41
| -6% | -$2.25K |
|
|
KG
3865
Kestrel Group
KG
$69.4M
| $33K | ﹤0.01% |
938
+17
| +2% | +$631 |
|
|
LUNA
3866
DELISTED
Luna Innovations Incorporated
LUNA
| $32.9K | ﹤0.01% |
5,615
-799
| -12% | -$6.05K |
|
|
MOND
3867
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $32.8K | ﹤0.01% |
9,186
+128
| +1% | +$858 |
|
3868
Sight Sciences
SGHT
$286M
| $32.5K | ﹤0.01% |
9,644
| – | – |
|
|
BLFY
3869
DELISTED
Blue Foundry Bancorp
BLFY
| $32.5K | ﹤0.01% |
3,881
-1,679
| -30% | -$16K |
|
3870
Capital Bancorp
CBNK
$608M
| $32.4K | ﹤0.01% |
1,693
-426
| -20% | -$8.26K |
|
|
TRUE
3871
DELISTED
TrueCar
TRUE
| $32.3K | ﹤0.01% |
15,616
-1,976
| -11% | -$4.53K |
|
3872
Similarweb
SMWB
$628M
| $32.2K | ﹤0.01% |
4,966
+4,373
| +737% | +$28.6K |
|
3873
American Express Global Business Travel
GBTG
$4.93B
| $32.1K | ﹤0.01% |
5,828
-636
| -10% | -$4.1K |
|
|
VISL
3874
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
| $32K | ﹤0.01% |
8,750
| – | – |
|
3875
Acacia Research
ACTG
$428M
| $31.9K | ﹤0.01% |
8,740
+1,144
| +15% | +$4.38K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.